Effect of singing lessons on breathlessness in patients with chronic obstructive pulmonary disease (COPD)

ISRCTN ISRCTN17544114
DOI https://doi.org/10.1186/ISRCTN17544114
Secondary identifying numbers cro870 protocol version 2
Submission date
16/01/2009
Registration date
19/02/2009
Last edited
11/12/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Nicholas Hopkinson
Scientific

Royal Brompton Hospital
Fulham Road
London
SW3 6NP
United Kingdom

Study information

Study designRandomised controlled single-blind trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffect of singing lessons on breathlessness in patients with chronic obstructive pulmonary disease (COPD): a randomised controlled single-blind trial
Study acronymESLBPC
Study objectivesThat a course of singing lessons will improve breathlessness in patients with chronic obstructive pulmonary disease (COPD).
Ethics approval(s)Brompton, Harefield and National Heart and Lung Institute (NHLI) REC, approved on 11/10/2007 (ref: 07/H0708/90)
Health condition(s) or problem(s) studiedChronic obstructive pulmonary disease (COPD)
InterventionParticipants will be randomly allocate to the following two arms:
Intervention group: A 6-week course of singing lessons (1 hour/ lesson) twice weekly
Control group: Standard care only
Intervention typeOther
Primary outcome measureSingle breath counting and breath hold time.

All primary and secondary outcomes will be assessed at 7 weeks.
Secondary outcome measures1. Quality of life (QOL): St George's Respiratory Questionnaire (SGRQ), Transition Dyspnoea Index, SF-36® Health Survey
2. Shuttle walking test (SWT)

All primary and secondary outcomes will be assessed at 7 weeks.
Overall study start date22/01/2009
Completion date01/08/2009

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants64
Key inclusion criteria1. Both males and females, no age limits
2. COPD patients able to comply with a course of lessons
3. Medical Research Council (MRC) dyspnoea score >3/5
Key exclusion criteriaUnable to comply with course
Date of first enrolment22/01/2009
Date of final enrolment01/08/2009

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Royal Brompton Hospital
London
SW3 6NP
United Kingdom

Sponsor information

Imperial College London (UK)
University/education

c/o Gary Roper
South Kensington Campus
London
SW7 2AZ
England
United Kingdom

Website http://www3.imperial.ac.uk/
ROR logo "ROR" https://ror.org/041kmwe10

Funders

Funder type

Charity

Royal Brompton & Harefield Arts (rb&h Arts), Royal Brompton Hospital (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Abstract results 18/05/2010 No No
Results article results 03/08/2010 Yes No